Risk factor
Limited trading liquidity
Profitability factor
Greatly undervalued vs peers
About
Daewoong Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceuticals. It also engages in the leasing of real estates. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd. in 2002. Daewoong Co., Ltd. was founded in 1961 and is headquartered in Seongnam-si, South Korea.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITD.
Target Price
The average target price of 003090.KS is 28000 and suggests 21% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to
Buy
Sell